학술논문

Improvements in Survival and Clinical Benefit With Gemcitabine as First-Line Therapy for Patients With Advanced Pancreas Cancer: A Randomized Trial.
Document Type
Article
Source
Journal of Clinical Oncology; 12/20/2023, Vol. 41 Issue 36, p5482-5492, 11p
Subject
Language
ISSN
0732183X